MDS | Tumor

Having Cancer Makes Me Live on the Edge, Though I Never Asked To

May 20th 2022

Cancer is a dangerous disease that comes with many difficult decisions, making me constantly feel like I’m living on the edge.

While I Appreciate the Concern, Think Before Speaking to Cancer Survivors

April 28th 2022

Well-meaning comments can come off as bothersome — or even hurtful — to me as I navigate cancer.

FDA OKs Continued Enrollment in Ongoing Blood Cancer Clinical Trials After Gilead Addresses Safety Concerns

April 15th 2022

Earlier in the year, clinical trials assessing magrolimab for myelodysplastic syndrome and acute myeloid leukemia were put on a partial clinical hold, but now the FDA said that they can start enrolling patients again.

The Start of 2022 Sucked, But I'm Slowly Getting 'Back in the Race'

April 14th 2022

Early 2022 was difficult for me, with the death of my dog and some difficult cancer-related situations, but thankfully, I know wonderful people who helped pull me out of my slump.

FDA Halts Several Studies Examining Magrolimab-Onureg Combo Across Multiple Cancer Types Due to Serious Side Effects

January 28th 2022

All clinical trials investigating the combination of magrolimab and the chemotherapy Onureg have been paused due to unforeseen serious side effects experienced by patients with various blood cancers receiving the treatment.

mRNA COVID-19 Vaccination Sparks Strong Antibody Response in Patients With AML and MDS

December 13th 2021

Most patients with acute myeloid leukemia and myelodysplastic syndrome achieved strong antibody responses to COVID-19 vaccination, according to recent study results.

There’s Always Hope After an ‘Incurable’ Cancer Diagnosis, Thanks to Devoted Researchers

November 18th 2021

A cancer survivor explains how the new treatments coming out for all types of cancer give her hope. “If we are diagnosed today, a cure or remission may come out next week or next month, or next year to give us additional time to live,” she writes.

Phase 2 Trial Initiated for Second Line Treatment of AML and MDS

November 18th 2021

A phase 2 trial of aspacytarabine (BST-236) was initiated in patients with AML and MDS.

Cancer Survivors Are All on a Journey

September 30th 2021

A cancer survivor explains why each person experiences cancer differently – from side effects to treatments and more.

In the Mist of My Fear: Experiences With MDS

August 10th 2021

A patient with MDS writes about facing fears during the treatment journey.

The Basics of MDS: Diagnosis and Staging

August 4th 2021

How are myelodysplastic syndromes diagnosed and staged? What causes them? An expert from Moffit Cancer Center offers insight.

FDA Grants Venclexta/Onureg a Breakthrough Therapy Designation for Untreated MDS

July 22nd 2021

The FDA will expedite the development and review of the drug combination to treat untreated intermediate- high- and very high-risk myelodysplastic syndrome.

Vidaza With Novel Drug Shows Improvement for Myelodysplastic Syndromes With Genetic Mutations and Acute Myeloid Leukemia

April 2nd 2021

Previously, Vidaza alone showed poor response rates for patients with TP53-mutated, myelodysplastic syndromes and acute myeloid leukemia, but adding the novel agent eprenetapopt improved response rates and overall survival in this patient population.

A Multidisciplinary Team in Treating Myelodysplastic Syndromes

December 17th 2020

Possible Treatment Options for Myelodysplastic Syndromes

December 17th 2020

Luspatercept in the Treatment of Myelodysplastic Syndromes

December 17th 2020

Understanding the MEDALIST Trial

December 17th 2020

Treatment Goals in Myelodysplastic Syndromes

December 17th 2020

Therapy Options in Low-Risk Myelodysplastic Syndromes

December 17th 2020

Treatment Approach in Myelodysplastic Syndromes

December 17th 2020

NGS in Myelodysplastic Syndromes

December 17th 2020

Risk Assessment & Genetic Testing in Myelodysplastic Syndromes

December 17th 2020

Monocytosis in Myelodysplastic Syndromes

December 17th 2020

Work-up of Myelodysplastic Syndromes

December 17th 2020

An Overview of Myelodysplastic Syndromes

December 17th 2020

Oncology Nurses Are a Blessing

July 28th 2020

Before I became ill, I had wondered why anyone would want to work in a field where they knew people might die. But after meeting some incredible nurses during my cancer journey, I now know why.

FDA Approves Oral Combination of Dacogen and Cedazuridine for Patients with Myelodysplastic Syndromes

July 8th 2020

The Food and Drug Administration approved the oral combination of Inquovi (Dacogen [decitabine] and cedazuridine) for certain adult patients with myelodysplastic syndromes (MDS).

Getting Treatment During a Pandemic

May 24th 2020

A cancer survivor describes the changes of going for treatment during the pandemic.

Which Is Worse, Cancer or Treatment?

February 15th 2020

A cancer survivor often contemplates which is the lesser of two evils – cancer or treatment?

Cancer Is a Lot Like Drawing

December 4th 2019

What do erasers, drawings, cancer and life all have in common? More than you might think.